These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

290 related articles for article (PubMed ID: 31827795)

  • 1. Clinical course and management of idiopathic pulmonary fibrosis.
    Quinn C; Wisse A; Manns ST
    Multidiscip Respir Med; 2019; 14():35. PubMed ID: 31827795
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Idiopathic pulmonary fibrosis: a holistic approach to disease management in the antifibrotic age.
    Shaw J; Marshall T; Morris H; Hayton C; Chaudhuri N
    J Thorac Dis; 2017 Nov; 9(11):4700-4707. PubMed ID: 29268540
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Possible value of antifibrotic drugs in patients with progressive fibrosing non-IPF interstitial lung diseases.
    Torrisi SE; Kahn N; Wälscher J; Sarmand N; Polke M; Lars K; Eichinger M; Heussel CP; Palmucci S; Sambataro FM; Sambataro G; Sambataro D; Vancheri C; Kreuter M
    BMC Pulm Med; 2019 Nov; 19(1):213. PubMed ID: 31718637
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Management of Idiopathic Pulmonary Fibrosis.
    Pleasants R; Tighe RM
    Ann Pharmacother; 2019 Dec; 53(12):1238-1248. PubMed ID: 31280590
    [No Abstract]   [Full Text] [Related]  

  • 5. Overview of idiopathic pulmonary fibrosis (IPF) and evidence-based guidelines.
    Sharif R
    Am J Manag Care; 2017 Jul; 23(11 Suppl):S176-S182. PubMed ID: 28978212
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Idiopathic Pulmonary Fibrosis for Cardiologists: Differential Diagnosis, Cardiovascular Comorbidities, and Patient Management.
    van Cleemput J; Sonaglioni A; Wuyts WA; Bengus M; Stauffer JL; Harari S
    Adv Ther; 2019 Feb; 36(2):298-317. PubMed ID: 30554332
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comorbidities, Complications and Non-Pharmacologic Treatment in Idiopathic Pulmonary Fibrosis.
    Millan-Billi P; Serra C; Alonso Leon A; Castillo D
    Med Sci (Basel); 2018 Jul; 6(3):. PubMed ID: 30042369
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diagnosis and management of idiopathic pulmonary fibrosis: Thoracic Society of Australia and New Zealand and Lung Foundation Australia position statements summary.
    Jo HE; Prasad JD; Troy LK; Mahar A; Bleasel J; Ellis SJ; Chambers DC; Holland AE; Lake FR; Keir G; Goh NS; Wilsher M; de Boer S; Moodley Y; Grainge C; Whitford HM; Chapman SA; Reynolds PN; Beatson D; Jones LJ; Hopkins P; Allan HM; Glaspole I; Corte TJ
    Med J Aust; 2018 Feb; 208(2):82-88. PubMed ID: 29385965
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A cohort study of Danish patients with interstitial lung diseases: burden, severity, treatment and survival.
    Hyldgaard C
    Dan Med J; 2015 Apr; 62(4):B5069. PubMed ID: 25872544
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comorbid Conditions in Idiopathic Pulmonary Fibrosis: Recognition and Management.
    Oldham JM; Collard HR
    Front Med (Lausanne); 2017; 4():123. PubMed ID: 28824912
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comorbidities and Complications in Idiopathic Pulmonary Fibrosis.
    Cano-Jiménez E; Hernández González F; Peloche GB
    Med Sci (Basel); 2018 Aug; 6(3):. PubMed ID: 30200249
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The accuracy of the clinical diagnosis of new-onset idiopathic pulmonary fibrosis and other interstitial lung disease: A prospective study.
    Raghu G; Mageto YN; Lockhart D; Schmidt RA; Wood DE; Godwin JD
    Chest; 1999 Nov; 116(5):1168-74. PubMed ID: 10559072
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Progression in the Management of Non-Idiopathic Pulmonary Fibrosis Interstitial Lung Diseases, Where Are We Now and Where We Would Like to Be.
    Goos T; De Sadeleer LJ; Yserbyt J; Verleden GM; Vermant M; Verleden SE; Wuyts WA
    J Clin Med; 2021 Mar; 10(6):. PubMed ID: 33807034
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Idiopathic Pulmonary Fibrosis and the Elderly: Diagnosis and Management Considerations.
    Jo HE; Randhawa S; Corte TJ; Moodley Y
    Drugs Aging; 2016 May; 33(5):321-34. PubMed ID: 27083934
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pulmonary hypertension in chronic lung diseases.
    Seeger W; Adir Y; Barberà JA; Champion H; Coghlan JG; Cottin V; De Marco T; Galiè N; Ghio S; Gibbs S; Martinez FJ; Semigran MJ; Simonneau G; Wells AU; Vachiéry JL
    J Am Coll Cardiol; 2013 Dec; 62(25 Suppl):D109-16. PubMed ID: 24355635
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Current approaches to the management of idiopathic pulmonary fibrosis.
    Raghu G; Richeldi L
    Respir Med; 2017 Aug; 129():24-30. PubMed ID: 28732832
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Validation of the risk stratification score in idiopathic pulmonary fibrosis: study protocol of a prospective, multi-centre, observational, 3-year clinical trial.
    Manzetti GM; Hosein K; Cecchini MJ; Kwan K; Abdelrazek M; Zompatori M; Rogliani P; Mura M
    BMC Pulm Med; 2021 Dec; 21(1):396. PubMed ID: 34863146
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High Oxygen Delivery to Preserve Exercise Capacity in Patients with Idiopathic Pulmonary Fibrosis Treated with Nintedanib. Methodology of the HOPE-IPF Study.
    Ryerson CJ; Camp PG; Eves ND; Schaeffer M; Syed N; Dhillon S; Jensen D; Maltais F; O'Donnell DE; Raghavan N; Roman M; Stickland MK; Assayag D; Bourbeau J; Dion G; Fell CD; Hambly N; Johannson KA; Kalluri M; Khalil N; Kolb M; Manganas H; Morán-Mendoza O; Provencher S; Ramesh W; Rolf JD; Wilcox PG; Guenette JA
    Ann Am Thorac Soc; 2016 Sep; 13(9):1640-7. PubMed ID: 27348402
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The clinical impact of major comorbidities on idiopathic pulmonary fibrosis.
    Suzuki A; Kondoh Y
    Respir Investig; 2017 Mar; 55(2):94-103. PubMed ID: 28274539
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 15.